Survival analysis based on TNM classification revealed that the patients with high NLR/Alb had significantly poorer prognoses for 3Y OS and 3Y RFS rates than those with low NLR/Alb, especially those with pStage II/III GC (74.3% vs. 94.5%, p = 0.005 and 63.7% vs. 92.0%, p = 0.002) (Figure S2). Here, ALB is linked to gastric cancer.